Evidence map›Paper›PMID 33680094›Full record

ArticleTherapeutic advances in urology

Next generation sequencing in patients with nephrolithiasis: how does it perform compared with standard urine and stone cultures?

Charles U Nottingham, Mark A Assmus, Alexander W Peters, Tim Large, Deepak K Agarwal, Marcelino E Rivera, Amy E Krambeck

Open access · goldAbstract read
In one paragraph

Article in Therapeutic advances in urology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Charles U NottinghamDepartment of Urology, Indiana University School of Medicine, Indianapolis, IN, USA.ORCID https://orcid.org/0000-0002-1972-0230
Mark A AssmusDepartment of Urology, Indiana University School of Medicine, Indianapolis, IN, USA.ORCID https://orcid.org/0000-0003-3615-9251
Alexander W PetersDepartment of Urology, Indiana University School of Medicine, Indianapolis, IN, USA.
Tim LargeDepartment of Urology, Indiana University School of Medicine, Indianapolis, IN, USA.
Deepak K AgarwalDepartment of Urology, Indiana University School of Medicine, Indianapolis, IN, USA.
Marcelino E RiveraDepartment of Urology, Indiana University School of Medicine, Indianapolis, IN, USA.
Amy E KrambeckDepartment of Urology, Indiana University School of Medicine, Indianapolis, IN, USA.
Indiana University School of Medicine

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOur aim was to compare microorganism detection between standard culture (Ctx) and next generation sequencing (NGS) in patients undergoing surgery for nephrolithiasis; we prospectively compared both urine and stone culture results using these two techniques.

methodsWe prospectively compared microorganism detection of urine and stone cultures using Ctx

resultsWe prospectively evaluated 84 patients. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of Voided Ctx predicting Stone Ctx were 66.7%, 73.7%, 54.5%, and 82.4%, respectively. Concordance of Voided Ctx microorganisms to Stone microorganisms decreased when NGS was used for the Stone compared with Ctx. The sensitivity, specificity, PPV, and NPV of Voided NGS to predict Stone Ctx microorganisms were 85.2%, 24.6%, 34.8%, and 77.8%, respectively. The concordance of Voided NGS to Stone microorganisms improved when the Stone was analyzed

conclusionNGS has a higher detection rate of microorganisms than standard culture for both preoperative urine and stone cultures. Voided NGS was the most sensitive in predicting a positive Stone sample, but the specificity and PPV were, overall, low. Further correlation of NGS microorganism detection with patient outcomes will determine which clinical situations may benefit most from NGS

Indexed as

bacteriuriainfectionnephrolithiasisnext generation sequencing

Identifiers

PMID33680094
PMCPMC7900788
OpenAlexW3130409018

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.